Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic
  • Search Hotels in Pleasanton

  • ROOMS:

Record-breaking Achievement at Rady Children's Institute for Genomic Medicine

By: 3BL Media

SOURCE: Illumina


Minutes matter when a critically ill baby needs a genome-based diagnosis and the team at Rady Children's Institute for Genomic Medicine accomplished a huge breakthrough last week. The team sequenced the genome of a critically ill infant to provide a clinical diagnosis in a record-breaking 13.5 hours, leading to implementation of life-saving treatment 4 hours later. This milestone, achieved in collaboration with technology partners at Illumina and Alexion Pharmaceuticals, Inc., shows that in the future, it will be possible for clinicians to order whole genome sequencing on morning rounds and receive a molecular diagnosis by the same evening. "I believe we finally have the technology solution to end suffering and death associated with failure to diagnose genetic disease. Read our letter published in The New England Journal of Medicine." - Stephen Kingsmore, President/CEO at Rady Children's Institute for Genomic Medicine. 

Illumina is proud to partner with Rady Children's Institute for Genomic Medicine to help implement rapid whole genome sequencing.  Through innovation, philanthrophy, education and collaboration, we will break down barriers and continue to seek new ways to drive progress in the adoption of genomics for all. 

Tweet me: "@Illumina is proud to partner with @radychildrens to help implement rapid whole genome sequencing within a medical delivery system that is unparalleled. This is a tangible change that can improve patient outcome and save lives." - Phil Febbo, CMO Illumina

KEYWORDS: illumina, Rady Children's Institute for Genomic Medicine, NASDAQ:ILM

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Photography by Christophe Tomatis
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.